Ipca Laboratories Limited, headquartered in Mumbai, India, is a leading manufacturer and distributor of pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India. With a wide range of therapeutic segments, the company specializes in producing APIs for anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic treatments. In addition to APIs, Ipca Laboratories also offers generic and branded formulations for various therapeutic areas, including but not limited to allergy, cancer drugs, cardiology, dermatology, diabetology, gastroenterology, neurology, ophthalmology, psychiatry, and urology. The company's commitment to quality and innovation has enabled it to export its products to approximately 100 countries worldwide. Since its establishment in 1949, Ipca Laboratories has been dedicated to improving healthcare outcomes and continues to be a trusted name in the pharmaceutical industry.
Navigation section
IPCA Laboratories Limited
- 1,535.00 11.25(0.74%) 1,537.75 13.55(0.89%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,517.85 1,522.75 | 1,554.75 1554.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 1,041.00 (21-Dec-2023) 1,042.00 (21-Dec-2023) | 1,708.65 (15-Oct-2024) 1,708.70 (14-Oct-2024) |
- Open
- 1,517.85 1,529.95
- Previous Close
- 1,523.75 1,524.20
- Volume
- 3.12
- Total Traded value
- 48.00 (₹ Lakhs)
- Upper circuit
- 1,676.10 1,258.55
- Lower circuit
- 1,371.40 1,029.75
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 3 | 0 |
| Bid Price | Quantity |
|---|---|
| 1,534.35 | 3.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 3 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹389.44 Cr |
| PE Ratio (TTM): | 60.02 |
| PB Ratio: | 5.79 |
| Industry P/E: | 61.74 |
| Debt to Equity: | 0.00 |
| ROE: | 9.65 |
| EPS (TTM): | 25.62 |
| Book Value: | 28.05 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Sep, 2023 | Sep, 2023 | Jun, 2023 | Jun, 2023 | |
|---|---|---|---|---|---|
| Revenue | 566.90 Cr | 2,334.40 Cr | 193.32 Cr | 261.11 Cr | 1,488.71 Cr |
| Profit | 18.45 Cr | 420.27 Cr | 0.11 Cr | 19.25 Cr | 166.58 Cr |
| Expense | 565.57 Cr | 1,895.35 Cr | 193.41 Cr | 249.34 Cr | 1,282.29 Cr |
| Comprehensive income | 18.47 Cr | 417.08 Cr | 1.42 Cr | 19.35 Cr | 166.11 Cr |
| EPS | 0.86 | 2.37 | 0.01 | 0.74 | 6.57 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| IPCA Laboratories Limited | Feb, 1995 May, 1994 | Pharmaceuticals Pharmaceuticals | IPCALAB IPCALAB |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
IPCA Laboratories Limited FAQ's
What is the range of today's stock performance for IPCA Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,517.85 on the NSE (National Stock Exchange) to a maximum of 1,554.75. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,522.75 to a high of 1,554.00.
What are the 52-week low and high values for IPCA Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 1,041.00 (occurred on 21-Dec-2023) and a high of 1,708.65 (achieved on 15-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,042.00 (on 21-Dec-2023), and the 52-week high is 1,708.70 (on 14-Oct-2024).
What was the opening and previous closing prices for IPCA Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 1,041.00 (occurred on 21-Dec-2023) and a high of 1,708.65 (achieved on 15-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,042.00 (on 21-Dec-2023), and the 52-week high is 1,708.70 (on 14-Oct-2024).
What is the total volume and traded value for IPCA Laboratories Limited for the day?
The total volume is 3, and the total traded value is 48.00 (₹ Lakhs).
What are the upper and lower circuit limits for IPCA Laboratories Limited?
The upper circuit limit is 1,676.10, and the lower circuit limit is 1,371.40.
What is the market cap and PE ratio for IPCA Laboratories Limited?
The market cap is ₹389.44 Cr, and the PE ratio (TTM) is 57.70.
What is the PB ratio, industry P/E, and debt to equity ratio for IPCA Laboratories Limited?
The PB ratio is 54.73, industry P/E is 61.74 , and the debt to equity ratio is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for IPCA Laboratories Limited?
ROE is 9.65, EPS is 25.62, book value is 28.05
What are the revenue and profit figures for the latest quarter and previous quarters for IPCA Laboratories Limited?
In Sep 2023, Revenue is ₹5669000000.00, and Profit is ₹184500000.00. In Sep 2023, Revenue is ₹23344000000.00, and Profit is ₹4202700000.00.
When was IPCA Laboratories Limited listed, and what industry does it belong to?
The company, IPCA Laboratories Limited, was listed in Feb 1995 and belongs to the Pharmaceuticals industry. Its NSE symbol is IPCALAB.
What is the current shareholding pattern of the IPCA Laboratories Limited?
As of latest available update, promoters hold 46.29%, the public holds 53.71%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
